Ablynx, a Belgium company, pioneering in the discovery and development of Nanobodies(r), a novel class of antibody-derived therapeutic proteins, has extended its drug discovery and development alliance with Novartis for another year.

Greystone Associates , a medical and healthcare technology consulting firm in its new and comprehensive report: Microneedles in Medicine: Technology, Markets, and Prospects  states that employing  very small needles – microneedles – that can deliver drugs or sample analyte by mechanically perforating the outer skin layer.

Baxter Healthcare Corporation has introduced drug labels to help reduce medication errors by creating enhanced packaging that provides additional safeguards to assist clinicians in the correct identification of critical medications.

Nanotechnology holds great promise for the development of new treatments and diagnostics. Nanotechnology may provide new drugs that are able to reach specific areas of the body more effectively and at safer doses.